Treating brain cancer patients with a single drug often produces disappointing results. Your Cancer Today interviews Dr. Ronald A. DePinho,director of the Center for Applied Cancer Science at Dana-Farber Cancer Institute and professor of medicine at Harvard Medical School. Dr. DePinho recently completed a study-published in Science Magazine -- that suggested that many brain tumors should be genetically profiled and treated with multipledrugs.